Validation of safety outcomes in routinely collected data: Lessons learned from a multinational postapproval safety study Article Swipe
Patrick J. Arena
,
Kui Huang
,
Lukas Löfling
,
Shahram Bahmanyar
,
Jingping Mo
,
Stephen E. Schachterle
,
Anthony P. Nunes
,
Elisabeth Smits
,
Rosa Juuti
,
Fabian Hoti
,
Pasi Korhonen
,
Kasper Adelborg
,
Jens Sundbøll
,
Torben Riis Rasmussen
,
Anders Løkke
,
Véra Ehrenstein
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1002/pds.5582
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1002/pds.5582
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/pds.5582
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.5582
- OA Status
- hybrid
- Cited By
- 3
- References
- 15
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4311020523
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4311020523Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/pds.5582Digital Object Identifier
- Title
-
Validation of safety outcomes in routinely collected data: Lessons learned from a multinational postapproval safety studyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-12-10Full publication date if available
- Authors
-
Patrick J. Arena, Kui Huang, Lukas Löfling, Shahram Bahmanyar, Jingping Mo, Stephen E. Schachterle, Anthony P. Nunes, Elisabeth Smits, Rosa Juuti, Fabian Hoti, Pasi Korhonen, Kasper Adelborg, Jens Sundbøll, Torben Riis Rasmussen, Anders Løkke, Véra EhrensteinList of authors in order
- Landing page
-
https://doi.org/10.1002/pds.5582Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.5582Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.5582Direct OA link when available
- Concepts
-
Medicine, Pharmacoepidemiology, Multinational corporation, Medical emergency, Pharmacology, Law, Political science, Medical prescriptionTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
3Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2024: 1Per-year citation counts (last 5 years)
- References (count)
-
15Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4311020523 |
|---|---|
| doi | https://doi.org/10.1002/pds.5582 |
| ids.doi | https://doi.org/10.1002/pds.5582 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/36495188 |
| ids.openalex | https://openalex.org/W4311020523 |
| fwci | 1.25232249 |
| type | article |
| title | Validation of safety outcomes in routinely collected data: Lessons learned from a multinational postapproval safety study |
| biblio.issue | 5 |
| biblio.volume | 32 |
| biblio.last_page | 596 |
| biblio.first_page | 592 |
| grants[0].funder | https://openalex.org/F4320307765 |
| grants[0].award_id | |
| grants[0].funder_display_name | Pfizer |
| topics[0].id | https://openalex.org/T11235 |
| topics[0].field.id | https://openalex.org/fields/26 |
| topics[0].field.display_name | Mathematics |
| topics[0].score | 0.9965000152587891 |
| topics[0].domain.id | https://openalex.org/domains/3 |
| topics[0].domain.display_name | Physical Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2613 |
| topics[0].subfield.display_name | Statistics and Probability |
| topics[0].display_name | Statistical Methods in Clinical Trials |
| topics[1].id | https://openalex.org/T10845 |
| topics[1].field.id | https://openalex.org/fields/26 |
| topics[1].field.display_name | Mathematics |
| topics[1].score | 0.9887999892234802 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2613 |
| topics[1].subfield.display_name | Statistics and Probability |
| topics[1].display_name | Advanced Causal Inference Techniques |
| topics[2].id | https://openalex.org/T10417 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9871000051498413 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Lung Cancer Treatments and Mutations |
| funders[0].id | https://openalex.org/F4320307765 |
| funders[0].ror | https://ror.org/01xdqrp08 |
| funders[0].display_name | Pfizer |
| is_xpac | False |
| apc_list.value | 4740 |
| apc_list.currency | USD |
| apc_list.value_usd | 4740 |
| apc_paid.value | 4740 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 4740 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8766443729400635 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C23276603 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6063784956932068 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q158230 |
| concepts[1].display_name | Pharmacoepidemiology |
| concepts[2].id | https://openalex.org/C158016649 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6057794690132141 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q161726 |
| concepts[2].display_name | Multinational corporation |
| concepts[3].id | https://openalex.org/C545542383 |
| concepts[3].level | 1 |
| concepts[3].score | 0.3645361065864563 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2751242 |
| concepts[3].display_name | Medical emergency |
| concepts[4].id | https://openalex.org/C98274493 |
| concepts[4].level | 1 |
| concepts[4].score | 0.1611538529396057 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[4].display_name | Pharmacology |
| concepts[5].id | https://openalex.org/C199539241 |
| concepts[5].level | 1 |
| concepts[5].score | 0.0 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7748 |
| concepts[5].display_name | Law |
| concepts[6].id | https://openalex.org/C17744445 |
| concepts[6].level | 0 |
| concepts[6].score | 0.0 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q36442 |
| concepts[6].display_name | Political science |
| concepts[7].id | https://openalex.org/C2426938 |
| concepts[7].level | 2 |
| concepts[7].score | 0.0 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q3355478 |
| concepts[7].display_name | Medical prescription |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8766443729400635 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/pharmacoepidemiology |
| keywords[1].score | 0.6063784956932068 |
| keywords[1].display_name | Pharmacoepidemiology |
| keywords[2].id | https://openalex.org/keywords/multinational-corporation |
| keywords[2].score | 0.6057794690132141 |
| keywords[2].display_name | Multinational corporation |
| keywords[3].id | https://openalex.org/keywords/medical-emergency |
| keywords[3].score | 0.3645361065864563 |
| keywords[3].display_name | Medical emergency |
| keywords[4].id | https://openalex.org/keywords/pharmacology |
| keywords[4].score | 0.1611538529396057 |
| keywords[4].display_name | Pharmacology |
| language | en |
| locations[0].id | doi:10.1002/pds.5582 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S140231191 |
| locations[0].source.issn | 1053-8569, 1099-1557 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1053-8569 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Pharmacoepidemiology and Drug Safety |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.5582 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Pharmacoepidemiology and Drug Safety |
| locations[0].landing_page_url | https://doi.org/10.1002/pds.5582 |
| locations[1].id | pmid:36495188 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Pharmacoepidemiology and drug safety |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/36495188 |
| locations[2].id | pmh:oai:pure.atira.dk:openaire/a6145f1a-f724-41c9-a273-8fcd819dd071 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306400216 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Research Portal (King's College London) |
| locations[2].source.host_organization | https://openalex.org/I183935753 |
| locations[2].source.host_organization_name | King's College London |
| locations[2].source.host_organization_lineage | https://openalex.org/I183935753 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Arena, P J, Huang, K, Löfling, L, Bahmanyar, S, Mo, J, Schachterle, S E, Nunes, A P, Smits, E, Juuti, R, Hoti, F, Korhonen, P, Adelborg, K, Sundbøll, J, Rasmussen, T R, Løkke, A & Ehrenstein, V 2023, 'Validation of safety outcomes in routinely collected data : Lessons learned from a multinational postapproval safety study', Pharmacoepidemiology and Drug Safety, vol. 32, no. 5, pp. 592-596. https://doi.org/10.1002/pds.5582 |
| locations[2].landing_page_url | https://pure.au.dk/portal/en/publications/a6145f1a-f724-41c9-a273-8fcd819dd071 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5086636394 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-3024-771X |
| authorships[0].author.display_name | Patrick J. Arena |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I180857899 |
| authorships[0].affiliations[0].raw_affiliation_string | Global Medical Epidemiology, Pfizer Inc., New York, New York, USA |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I2799798094 |
| authorships[0].affiliations[1].raw_affiliation_string | Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, USA |
| authorships[0].institutions[0].id | https://openalex.org/I180857899 |
| authorships[0].institutions[0].ror | https://ror.org/01xdqrp08 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I180857899 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Pfizer (United States) |
| authorships[0].institutions[1].id | https://openalex.org/I2799798094 |
| authorships[0].institutions[1].ror | https://ror.org/01d88se56 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I2799798094 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | UCLA Health |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Patrick J. Arena |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, USA, Global Medical Epidemiology, Pfizer Inc., New York, New York, USA |
| authorships[1].author.id | https://openalex.org/A5026283971 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-4643-5029 |
| authorships[1].author.display_name | Kui Huang |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I180857899 |
| authorships[1].affiliations[0].raw_affiliation_string | Global Medical Epidemiology, Pfizer Inc., New York, New York, USA |
| authorships[1].institutions[0].id | https://openalex.org/I180857899 |
| authorships[1].institutions[0].ror | https://ror.org/01xdqrp08 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I180857899 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Pfizer (United States) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Kui Huang |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | Global Medical Epidemiology, Pfizer Inc., New York, New York, USA |
| authorships[2].author.id | https://openalex.org/A5011479329 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-2731-8532 |
| authorships[2].author.display_name | Lukas Löfling |
| authorships[2].countries | NO, SE |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1335113835, https://openalex.org/I28166907 |
| authorships[2].affiliations[0].raw_affiliation_string | Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital SE, Stockholm, Sweden |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I4210129856 |
| authorships[2].affiliations[1].raw_affiliation_string | Department of Research, Cancer Registry of Norway, Oslo, Norway |
| authorships[2].institutions[0].id | https://openalex.org/I4210129856 |
| authorships[2].institutions[0].ror | https://ror.org/03sm1ej59 |
| authorships[2].institutions[0].type | archive |
| authorships[2].institutions[0].lineage | https://openalex.org/I1333353642, https://openalex.org/I4210129856, https://openalex.org/I4210149801, https://openalex.org/I4210163359 |
| authorships[2].institutions[0].country_code | NO |
| authorships[2].institutions[0].display_name | Cancer Registry of Norway |
| authorships[2].institutions[1].id | https://openalex.org/I28166907 |
| authorships[2].institutions[1].ror | https://ror.org/056d84691 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I28166907 |
| authorships[2].institutions[1].country_code | SE |
| authorships[2].institutions[1].display_name | Karolinska Institutet |
| authorships[2].institutions[2].id | https://openalex.org/I1335113835 |
| authorships[2].institutions[2].ror | https://ror.org/00m8d6786 |
| authorships[2].institutions[2].type | healthcare |
| authorships[2].institutions[2].lineage | https://openalex.org/I1335113835 |
| authorships[2].institutions[2].country_code | SE |
| authorships[2].institutions[2].display_name | Karolinska University Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Lukas Löfling |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital SE, Stockholm, Sweden, Department of Research, Cancer Registry of Norway, Oslo, Norway |
| authorships[3].author.id | https://openalex.org/A5022338649 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-9205-6540 |
| authorships[3].author.display_name | Shahram Bahmanyar |
| authorships[3].countries | SE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1335113835, https://openalex.org/I28166907 |
| authorships[3].affiliations[0].raw_affiliation_string | Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital SE, Stockholm, Sweden |
| authorships[3].institutions[0].id | https://openalex.org/I28166907 |
| authorships[3].institutions[0].ror | https://ror.org/056d84691 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I28166907 |
| authorships[3].institutions[0].country_code | SE |
| authorships[3].institutions[0].display_name | Karolinska Institutet |
| authorships[3].institutions[1].id | https://openalex.org/I1335113835 |
| authorships[3].institutions[1].ror | https://ror.org/00m8d6786 |
| authorships[3].institutions[1].type | healthcare |
| authorships[3].institutions[1].lineage | https://openalex.org/I1335113835 |
| authorships[3].institutions[1].country_code | SE |
| authorships[3].institutions[1].display_name | Karolinska University Hospital |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Shahram Bahmanyar |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital SE, Stockholm, Sweden |
| authorships[4].author.id | https://openalex.org/A5110802306 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Jingping Mo |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I180857899 |
| authorships[4].affiliations[0].raw_affiliation_string | Safety Surveillance Research, Pfizer Inc., New York, New York, USA |
| authorships[4].institutions[0].id | https://openalex.org/I180857899 |
| authorships[4].institutions[0].ror | https://ror.org/01xdqrp08 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I180857899 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Pfizer (United States) |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Jingping Mo |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Safety Surveillance Research, Pfizer Inc., New York, New York, USA |
| authorships[5].author.id | https://openalex.org/A5057438185 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-6017-2670 |
| authorships[5].author.display_name | Stephen E. Schachterle |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I180857899 |
| authorships[5].affiliations[0].raw_affiliation_string | Global Medical Epidemiology, Pfizer Inc., New York, New York, USA |
| authorships[5].institutions[0].id | https://openalex.org/I180857899 |
| authorships[5].institutions[0].ror | https://ror.org/01xdqrp08 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I180857899 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Pfizer (United States) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Stephen E. Schachterle |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Global Medical Epidemiology, Pfizer Inc., New York, New York, USA |
| authorships[6].author.id | https://openalex.org/A5020649460 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-9102-3600 |
| authorships[6].author.display_name | Anthony P. Nunes |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I166722992 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I4210124242 |
| authorships[6].affiliations[1].raw_affiliation_string | Optum Inc., Boston, Massachusetts, USA |
| authorships[6].institutions[0].id | https://openalex.org/I4210124242 |
| authorships[6].institutions[0].ror | https://ror.org/0370sjj75 |
| authorships[6].institutions[0].type | company |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210124242 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Optum (United States) |
| authorships[6].institutions[1].id | https://openalex.org/I166722992 |
| authorships[6].institutions[1].ror | https://ror.org/0464eyp60 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I166722992 |
| authorships[6].institutions[1].country_code | US |
| authorships[6].institutions[1].display_name | University of Massachusetts Chan Medical School |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Anthony P. Nunes |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA, Optum Inc., Boston, Massachusetts, USA |
| authorships[7].author.id | https://openalex.org/A5015760602 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-1882-4748 |
| authorships[7].author.display_name | Elisabeth Smits |
| authorships[7].countries | NL |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210120609 |
| authorships[7].affiliations[0].raw_affiliation_string | PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands |
| authorships[7].institutions[0].id | https://openalex.org/I4210120609 |
| authorships[7].institutions[0].ror | https://ror.org/01wfg6h04 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210120609 |
| authorships[7].institutions[0].country_code | NL |
| authorships[7].institutions[0].display_name | Pharmo Institute |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Elisabeth Smits |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands |
| authorships[8].author.id | https://openalex.org/A5021433446 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Rosa Juuti |
| authorships[8].affiliations[0].raw_affiliation_string | EPID Research, Espoo, Finland |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Rosa Juuti |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | EPID Research, Espoo, Finland |
| authorships[9].author.id | https://openalex.org/A5089851017 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-7464-3549 |
| authorships[9].author.display_name | Fabian Hoti |
| authorships[9].affiliations[0].raw_affiliation_string | EPID Research, Espoo, Finland |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Fabian Hoti |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | EPID Research, Espoo, Finland |
| authorships[10].author.id | https://openalex.org/A5011985370 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-4815-2455 |
| authorships[10].author.display_name | Pasi Korhonen |
| authorships[10].affiliations[0].raw_affiliation_string | EPID Research, Espoo, Finland |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Pasi Korhonen |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | EPID Research, Espoo, Finland |
| authorships[11].author.id | https://openalex.org/A5042776932 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-5639-7252 |
| authorships[11].author.display_name | Kasper Adelborg |
| authorships[11].countries | DK |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I2802335433 |
| authorships[11].affiliations[0].raw_affiliation_string | Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus N, Denmark |
| authorships[11].institutions[0].id | https://openalex.org/I2802335433 |
| authorships[11].institutions[0].ror | https://ror.org/040r8fr65 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I2802335433 |
| authorships[11].institutions[0].country_code | DK |
| authorships[11].institutions[0].display_name | Aarhus University Hospital |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Kasper Adelborg |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus N, Denmark |
| authorships[12].author.id | https://openalex.org/A5072361572 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-1276-1419 |
| authorships[12].author.display_name | Jens Sundbøll |
| authorships[12].countries | DK |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I2802335433 |
| authorships[12].affiliations[0].raw_affiliation_string | Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus N, Denmark |
| authorships[12].institutions[0].id | https://openalex.org/I2802335433 |
| authorships[12].institutions[0].ror | https://ror.org/040r8fr65 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I2802335433 |
| authorships[12].institutions[0].country_code | DK |
| authorships[12].institutions[0].display_name | Aarhus University Hospital |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Jens Sundbøll |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus N, Denmark |
| authorships[13].author.id | https://openalex.org/A5048895443 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-7030-9260 |
| authorships[13].author.display_name | Torben Riis Rasmussen |
| authorships[13].countries | DK |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I2802335433 |
| authorships[13].affiliations[0].raw_affiliation_string | Department of Respiratory Diseases and Allergology, Aarhus University Hospital, Aarhus N, Denmark |
| authorships[13].institutions[0].id | https://openalex.org/I2802335433 |
| authorships[13].institutions[0].ror | https://ror.org/040r8fr65 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I2802335433 |
| authorships[13].institutions[0].country_code | DK |
| authorships[13].institutions[0].display_name | Aarhus University Hospital |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Torben Riis Rasmussen |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Department of Respiratory Diseases and Allergology, Aarhus University Hospital, Aarhus N, Denmark |
| authorships[14].author.id | https://openalex.org/A5020135918 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-6905-4141 |
| authorships[14].author.display_name | Anders Løkke |
| authorships[14].countries | DK |
| authorships[14].affiliations[0].raw_affiliation_string | Department of Medicine, Little Belt Hospital, Vejle, Denmark |
| authorships[14].affiliations[1].institution_ids | https://openalex.org/I177969490 |
| authorships[14].affiliations[1].raw_affiliation_string | Department of Regional Health Research, University of Southern Denmark, Odense, Denmark |
| authorships[14].institutions[0].id | https://openalex.org/I177969490 |
| authorships[14].institutions[0].ror | https://ror.org/03yrrjy16 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I177969490 |
| authorships[14].institutions[0].country_code | DK |
| authorships[14].institutions[0].display_name | University of Southern Denmark |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Anders Løkke |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Department of Medicine, Little Belt Hospital, Vejle, Denmark, Department of Regional Health Research, University of Southern Denmark, Odense, Denmark |
| authorships[15].author.id | https://openalex.org/A5084136574 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-3415-3254 |
| authorships[15].author.display_name | Véra Ehrenstein |
| authorships[15].affiliations[0].raw_affiliation_string | EPID Research, Espoo, Finland |
| authorships[15].author_position | last |
| authorships[15].raw_author_name | Vera Ehrenstein |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | EPID Research, Espoo, Finland |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.5582 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Validation of safety outcomes in routinely collected data: Lessons learned from a multinational postapproval safety study |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11235 |
| primary_topic.field.id | https://openalex.org/fields/26 |
| primary_topic.field.display_name | Mathematics |
| primary_topic.score | 0.9965000152587891 |
| primary_topic.domain.id | https://openalex.org/domains/3 |
| primary_topic.domain.display_name | Physical Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2613 |
| primary_topic.subfield.display_name | Statistics and Probability |
| primary_topic.display_name | Statistical Methods in Clinical Trials |
| related_works | https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725 |
| cited_by_count | 3 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1002/pds.5582 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S140231191 |
| best_oa_location.source.issn | 1053-8569, 1099-1557 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1053-8569 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Pharmacoepidemiology and Drug Safety |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.5582 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Pharmacoepidemiology and Drug Safety |
| best_oa_location.landing_page_url | https://doi.org/10.1002/pds.5582 |
| primary_location.id | doi:10.1002/pds.5582 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S140231191 |
| primary_location.source.issn | 1053-8569, 1099-1557 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1053-8569 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Pharmacoepidemiology and Drug Safety |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.5582 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Pharmacoepidemiology and Drug Safety |
| primary_location.landing_page_url | https://doi.org/10.1002/pds.5582 |
| publication_date | 2022-12-10 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W2055557358, https://openalex.org/W4210756947, https://openalex.org/W2298338128, https://openalex.org/W2790381016, https://openalex.org/W3118976294, https://openalex.org/W2104830962, https://openalex.org/W2099530756, https://openalex.org/W3087219094, https://openalex.org/W1881150029, https://openalex.org/W1479832398, https://openalex.org/W2551469077, https://openalex.org/W2469589993, https://openalex.org/W2418833034, https://openalex.org/W2144409155, https://openalex.org/W3038536745 |
| referenced_works_count | 15 |
| abstract_inverted_index.Abstract | 0 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 90 |
| corresponding_author_ids | https://openalex.org/A5026283971 |
| countries_distinct_count | 5 |
| institutions_distinct_count | 16 |
| corresponding_institution_ids | https://openalex.org/I180857899 |
| citation_normalized_percentile.value | 0.73945603 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |